TY - JOUR
T1 - Chitin stimulates production of the antibiotic andrimid in a Vibrio corallilyticus strain
AU - Wietz, Matthias
AU - Månsson, Maria
AU - Gram, Lone
PY - 2011
Y1 - 2011
N2 - Vibrio coralliilyticus is a putative coral pathogen in
tropical oceans, but also possesses antagonistic
traits. We previously reported antibacterial activity in
Vibrio coralliilyticus strain S2052 based upon the
antibiotic andrimid. The purpose of the present study
was to determine whether V. coralliilyticus S2052
produces the antibiotic under conditions mimicking
natural habitats of vibrios. S2052 synthesized
andrimid with both chitin and macroalgal extracts as
sole nutrient source. With chitin, the biosynthesis of
metabolites other than andrimid was largely abolished,
and the yield of the antibiotic per cell was
twofold higher. In cultures with Artemia as live chitin
model system, S2052 reached up to 108 cells ml-1,
produced andrimid and showed attachment to the
exoskeleton and chitinous exuviae. The metabolic
focus on andrimid production with chitin indicates
that the antibiotic could serve an ecophysiological
function. S2052 was compared with two related V.
coralliilyticus strains (LMG20984T and LMG10953).
Despite overall similar secondary metabolomes,
LMG20984T and LMG10953 did not produce andrimid,
and their optimum biosynthetic temperature was 30
as compared with 25°C for S2052. In addition, S2052
appeared less pathogenic towards Artemia than
reported for the type strain. Different physiologies of
S2052 and closely related strains indicated that V.
coralliilyticus subspecies may be adapted to different
niches.
AB - Vibrio coralliilyticus is a putative coral pathogen in
tropical oceans, but also possesses antagonistic
traits. We previously reported antibacterial activity in
Vibrio coralliilyticus strain S2052 based upon the
antibiotic andrimid. The purpose of the present study
was to determine whether V. coralliilyticus S2052
produces the antibiotic under conditions mimicking
natural habitats of vibrios. S2052 synthesized
andrimid with both chitin and macroalgal extracts as
sole nutrient source. With chitin, the biosynthesis of
metabolites other than andrimid was largely abolished,
and the yield of the antibiotic per cell was
twofold higher. In cultures with Artemia as live chitin
model system, S2052 reached up to 108 cells ml-1,
produced andrimid and showed attachment to the
exoskeleton and chitinous exuviae. The metabolic
focus on andrimid production with chitin indicates
that the antibiotic could serve an ecophysiological
function. S2052 was compared with two related V.
coralliilyticus strains (LMG20984T and LMG10953).
Despite overall similar secondary metabolomes,
LMG20984T and LMG10953 did not produce andrimid,
and their optimum biosynthetic temperature was 30
as compared with 25°C for S2052. In addition, S2052
appeared less pathogenic towards Artemia than
reported for the type strain. Different physiologies of
S2052 and closely related strains indicated that V.
coralliilyticus subspecies may be adapted to different
niches.
U2 - 10.1111/j.1758-2229.2011.00259.x
DO - 10.1111/j.1758-2229.2011.00259.x
M3 - Journal article
C2 - 23761335
SN - 1758-2229
VL - 3
SP - 559
EP - 564
JO - Environmental Microbiology Reports
JF - Environmental Microbiology Reports
IS - 5
ER -